CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($) $ in Thousands | Common Stock | Additional Paid-in Capital | Retained Earnings (Deficit) | Accumulated Other Comprehensive (Loss) Income | Total |
Balance at beginning of period at Dec. 31, 2017 | $ 229 | $ 152,022 | $ (10,153) | $ (780) | $ 141,318 |
Balance at beginning of period (in shares) at Dec. 31, 2017 | 22,926,805 | | | | |
Increase (Decrease) in Stockholders' Equity | | | | | |
Impact of adopting ASUs | | | 43 | (43) | |
Net income (loss) | | | (1,709) | | (1,709) |
Unrealized income (loss) on foreign exchange rate translation | | | | (329) | |
Other comprehensive income (loss) | | | | (329) | (329) |
Issuance of common stock under stock compensation plans (in shares) | 8,334 | | | | |
Stock-based compensation expense | | 162 | | | 162 |
Issuance of common stock as compensation | | 73 | | | 73 |
Issuance of common stock as compensation (in shares) | 11,247 | | | | |
Shares exchanged for taxes on stock-based compensation | | (23) | | | (23) |
Shares exchanged for taxes on stock-based compensation (in shares) | (4,000) | | | | |
Balance at end of period at Mar. 31, 2018 | $ 229 | 152,234 | (11,819) | (1,152) | 139,492 |
Balance at end of period (in shares) at Mar. 31, 2018 | 22,942,386 | | | | |
Balance at beginning of period at Dec. 31, 2017 | $ 229 | 152,022 | (10,153) | (780) | 141,318 |
Balance at beginning of period (in shares) at Dec. 31, 2017 | 22,926,805 | | | | |
Increase (Decrease) in Stockholders' Equity | | | | | |
Net income (loss) | | | | | (12,591) |
Balance at end of period at Sep. 30, 2018 | $ 230 | 152,885 | (22,702) | (1,156) | 129,257 |
Balance at end of period (in shares) at Sep. 30, 2018 | 22,992,084 | | | | |
Balance at beginning of period at Mar. 31, 2018 | $ 229 | 152,234 | (11,819) | (1,152) | 139,492 |
Balance at beginning of period (in shares) at Mar. 31, 2018 | 22,942,386 | | | | |
Increase (Decrease) in Stockholders' Equity | | | | | |
Cash in lieu of fractional shares for stock dividend | | | (1) | | (1) |
Cash in lieu of fractional shares for stock dividend (in shares) | (101) | | | | |
Net income (loss) | | | (5,711) | | (5,711) |
Unrealized income (loss) on foreign exchange rate translation | | | | (220) | |
Other comprehensive income (loss) | | | | (220) | (220) |
Issuance of common stock under stock compensation plans (in shares) | 10,000 | | | | |
Stock-based compensation expense | | 221 | | | 221 |
Issuance of common stock as compensation | | 109 | | | 109 |
Issuance of common stock as compensation (in shares) | 14,359 | | | | |
Shares exchanged for taxes on stock-based compensation | | (16) | | | (16) |
Shares exchanged for taxes on stock-based compensation (in shares) | (2,200) | | | | |
Balance at end of period at Jun. 30, 2018 | $ 229 | 152,548 | (17,531) | (1,372) | 133,874 |
Balance at end of period (in shares) at Jun. 30, 2018 | 22,964,444 | | | | |
Increase (Decrease) in Stockholders' Equity | | | | | |
Net income (loss) | | | (5,171) | | (5,171) |
Unrealized income (loss) on foreign exchange rate translation | | | | 216 | |
Other comprehensive income (loss) | | | | 216 | 216 |
Issuance of common stock under stock compensation plans | $ 1 | (1) | | | |
Issuance of common stock under stock compensation plans (in shares) | 26,750 | | | | |
Stock-based compensation expense | | 340 | | | 340 |
Issuance of common stock as compensation | | 76 | | | 76 |
Issuance of common stock as compensation (in shares) | 12,235 | | | | |
Shares exchanged for taxes on stock-based compensation | | (78) | | | (78) |
Shares exchanged for taxes on stock-based compensation (in shares) | (11,345) | | | | |
Balance at end of period at Sep. 30, 2018 | $ 230 | 152,885 | (22,702) | (1,156) | 129,257 |
Balance at end of period (in shares) at Sep. 30, 2018 | 22,992,084 | | | | |
Balance at beginning of period at Dec. 31, 2018 | $ 230 | 153,268 | (34,518) | (1,964) | $ 117,016 |
Balance at beginning of period (in shares) at Dec. 31, 2018 | 23,018,441 | | | | 22,969,996 |
Increase (Decrease) in Stockholders' Equity | | | | | |
Net income (loss) | | | (137) | | $ (137) |
Unrealized income (loss) on foreign exchange rate translation | | | | 209 | |
Other comprehensive income (loss) | | | | 209 | 209 |
Issuance of common stock under stock compensation plans | $ 2 | (2) | | | |
Issuance of common stock under stock compensation plans (in shares) | 229,459 | | | | |
Stock-based compensation expense | | 297 | | | 297 |
Issuance of common stock as compensation | | 73 | | | 73 |
Issuance of common stock as compensation (in shares) | 24,785 | | | | |
Shares exchanged for taxes on stock-based compensation | | (206) | | | (206) |
Shares exchanged for taxes on stock-based compensation (in shares) | (53,201) | | | | |
Balance at end of period at Mar. 31, 2019 | $ 232 | 153,430 | (34,655) | (1,755) | 117,252 |
Balance at end of period (in shares) at Mar. 31, 2019 | 23,219,484 | | | | |
Balance at beginning of period at Dec. 31, 2018 | $ 230 | 153,268 | (34,518) | (1,964) | $ 117,016 |
Balance at beginning of period (in shares) at Dec. 31, 2018 | 23,018,441 | | | | 22,969,996 |
Increase (Decrease) in Stockholders' Equity | | | | | |
Net income (loss) | | | | | $ (9,385) |
Balance at end of period at Sep. 30, 2019 | $ 233 | 153,980 | (43,903) | (1,684) | $ 108,626 |
Balance at end of period (in shares) at Sep. 30, 2019 | 23,305,950 | | | | 23,257,505 |
Balance at beginning of period at Mar. 31, 2019 | $ 232 | 153,430 | (34,655) | (1,755) | $ 117,252 |
Balance at beginning of period (in shares) at Mar. 31, 2019 | 23,219,484 | | | | |
Increase (Decrease) in Stockholders' Equity | | | | | |
Net income (loss) | | | (11,246) | | (11,246) |
Unrealized income (loss) on foreign exchange rate translation | | | | 174 | |
Other comprehensive income (loss) | | | | 174 | 174 |
Issuance of common stock under stock compensation plans (in shares) | 34,000 | | | | |
Stock-based compensation expense | | 221 | | | 221 |
Issuance of common stock as compensation | $ 1 | 73 | | | 74 |
Issuance of common stock as compensation (in shares) | 29,016 | | | | |
Shares exchanged for taxes on stock-based compensation | | (30) | | | (30) |
Shares exchanged for taxes on stock-based compensation (in shares) | (12,400) | | | | |
Balance at end of period at Jun. 30, 2019 | $ 233 | 153,694 | (45,901) | (1,581) | 106,445 |
Balance at end of period (in shares) at Jun. 30, 2019 | 23,270,100 | | | | |
Increase (Decrease) in Stockholders' Equity | | | | | |
Net income (loss) | | | 1,998 | | 1,998 |
Unrealized income (loss) on foreign exchange rate translation | | | | (133) | |
Income tax expense (benefit) | | | | 30 | |
Other comprehensive income (loss) | | | | (103) | (103) |
Stock-based compensation expense | | 209 | | | 209 |
Issuance of common stock as compensation | | 77 | | | 77 |
Issuance of common stock as compensation (in shares) | 35,850 | | | | |
Balance at end of period at Sep. 30, 2019 | $ 233 | $ 153,980 | $ (43,903) | $ (1,684) | $ 108,626 |
Balance at end of period (in shares) at Sep. 30, 2019 | 23,305,950 | | | | 23,257,505 |